BACKGROUND: The sentinel lymph node (SLN) procedure has the potential to provide relevant improvement in nodal staging in colon cancer patients. However, there remains room for improvement for SLN identification and sensitivity. Therefore, the objective of the present investigation was to analyze factors influencing the success of the SLN procedure in colon cancer patients. METHODS: One hundred seventy-four consecutive colon cancer patients were prospectively enrolled in this multicenter study and underwent in vivo SLN procedure with isosulfan blue 1 % followed by open standard oncologic colon resection. Several patient-, tumor-, and procedure-related factors possibly influencing the SLN identification and sensitivity were analyzed. RESULTS: Sentinel lymph node identification rate and accuracy were 89.1 and 83.9 %, respectively. Successful identification of SLN was significantly associated with the intraoperative visualization of blue lymphatic vessels (p < 0.001) and with female gender (p = 0.024). True positive SLN results were significantly associated with higher numbers of SLN (p = 0.026) and with pN2 stage (p = 0.004). There was a trend toward better sensitivity in patients with lower body mass index (BMI) (p = 0.050). CONCLUSIONS: The success of the SLN procedure in colon cancer patients depends on both procedure-related factors (intraoperative visualization of blue lymphatic vessels, high number of SLN identified) and patient factors (gender, BMI). While patient factors can not be influenced, intraoperative visualization of blue lymphatics and identification of high numbers of SLN are key for a successful SLN procedure.
BACKGROUND: The sentinel lymph node (SLN) procedure has the potential to provide relevant improvement in nodal staging in colon cancerpatients. However, there remains room for improvement for SLN identification and sensitivity. Therefore, the objective of the present investigation was to analyze factors influencing the success of the SLN procedure in colon cancerpatients. METHODS: One hundred seventy-four consecutive colon cancerpatients were prospectively enrolled in this multicenter study and underwent in vivo SLN procedure with isosulfan blue 1 % followed by open standard oncologic colon resection. Several patient-, tumor-, and procedure-related factors possibly influencing the SLN identification and sensitivity were analyzed. RESULTS: Sentinel lymph node identification rate and accuracy were 89.1 and 83.9 %, respectively. Successful identification of SLN was significantly associated with the intraoperative visualization of blue lymphatic vessels (p < 0.001) and with female gender (p = 0.024). True positive SLN results were significantly associated with higher numbers of SLN (p = 0.026) and with pN2 stage (p = 0.004). There was a trend toward better sensitivity in patients with lower body mass index (BMI) (p = 0.050). CONCLUSIONS: The success of the SLN procedure in colon cancerpatients depends on both procedure-related factors (intraoperative visualization of blue lymphatic vessels, high number of SLN identified) and patient factors (gender, BMI). While patient factors can not be influenced, intraoperative visualization of blue lymphatics and identification of high numbers of SLN are key for a successful SLN procedure.
Authors: Aviram Nissan; Mladjan Protic; Anton J Bilchik; Robin S Howard; George E Peoples; Alexander Stojadinovic Journal: Ann Surg Date: 2012-09 Impact factor: 12.969
Authors: Anton J Bilchik; Maggie DiNome; Sukamal Saha; Roderick R Turner; David Wiese; Martin McCarter; Dave S B Hoon; Donald L Morton Journal: Arch Surg Date: 2006-06
Authors: Igor Langer; Ulrich Guller; Gilles Berclaz; Ossi R Koechli; Gabriel Schaer; Mathias K Fehr; Thomas Hess; Daniel Oertli; Lucio Bronz; Beate Schnarwyler; Edward Wight; Urs Uehlinger; Eduard Infanger; Daniel Burger; Markus Zuber Journal: Ann Surg Date: 2007-03 Impact factor: 12.969
Authors: Martijn Hgm van der Pas; Sybren Meijer; Otto S Hoekstra; Ingid I Riphagen; Henrica C W de Vet; Dirk L Knol; Nicole C T van Grieken; Wilhelmus J H J Meijerink Journal: Lancet Oncol Date: 2011-05-04 Impact factor: 41.316
Authors: Aviram Nissan; Mladjan Protic; Anton Bilchik; John Eberhardt; George E Peoples; Alexander Stojadinovic Journal: Ann Surg Date: 2010-02 Impact factor: 12.969
Authors: Andreas E Bembenek; Robert Rosenberg; Elke Wagler; Stephan Gretschel; Andreas Sendler; Joerg-Ruediger Siewert; Jörg Nährig; Helmut Witzigmann; Johann Hauss; Christian Knorr; Arno Dimmler; Jörn Gröne; Heinz-Johannes Buhr; Jörg Haier; Hermann Herbst; Juergen Tepel; Bence Siphos; Axel Kleespies; Alfred Koenigsrainer; Nikolas H Stoecklein; Olaf Horstmann; Robert Grützmann; Andreas Imdahl; Daniel Svoboda; Christian Wittekind; Wolfgang Schneider; Klaus-Dieter Wernecke; Peter M Schlag Journal: Ann Surg Date: 2007-06 Impact factor: 12.969
Authors: Alexander Stojadinovic; Aviram Nissan; Mladjan Protic; Carol F Adair; Diana Prus; Slavica Usaj; Robin S Howard; Dragan Radovanovic; Milan Breberina; Craig D Shriver; Ronit Grinbaum; Jeffery M Nelson; Tommy A Brown; Herbert R Freund; John F Potter; Tamar Peretz; George E Peoples Journal: Ann Surg Date: 2007-06 Impact factor: 12.969
Authors: Wendy Kelder; Andries E Braat; Arend Karrenbeld; Joris A K Grond; Johannes E De Vries; J Wolter A Oosterhuis; Peter C Baas; John T M Plukker Journal: Int J Colorectal Dis Date: 2007-07-12 Impact factor: 2.571
Authors: M Ankersmit; O S Hoekstra; A van Lingen; E Bloemena; M A J M Jacobs; D J Vugts; H J Bonjer; G A M S van Dongen; W J H J Meijerink Journal: Eur J Nucl Med Mol Imaging Date: 2019-02-23 Impact factor: 9.236
Authors: M Ankersmit; H J Bonjer; G Hannink; L J Schoonmade; M H G M van der Pas; W J H J Meijerink Journal: Tech Coloproctol Date: 2019-11-18 Impact factor: 3.781